Risk Factors and Clinical Aspects of Hepatitis B and C in Patients of Nasirabad District, Balochistan

Authors

  • Baz Muhammad Department of Paeds Medicine, Bolan Medical Complex and Hospital (BMCH), Quetta, Pakistan
  • Sana Ullah Department of Zoology, University of Balochistan, Quetta Pakistan
  • Hasina Jan Department of General Surgery, Bolan Medical Complex and Hospital (BMCH), Quetta, Pakistan
  • Bakhtawar Gul Kakar Department of Medicine & Allied, Bolan Medical Complex and Hospital (BMCH), Quetta, Pakistan
  • Amin Ullah Department of General Medicine, Bolan Medical Complex and Hospital (BMCH), Quetta, Pakistan
  • Inayat Ullah Department of Paediatrics, Children Hospital Quetta (CHQ), Quetta, Pakistan

DOI:

https://doi.org/10.31580/0827d008

Keywords:

Clinical aspects, Hepatitis B, Hepatitis C, Nasirabad, Risk factors

Abstract

Objective: With order to determine the frequency, sociodemographic traits, related risk factors, clinical and subclinical aspects of hepatitis B and hepatitis C in the local populace of Balochistan's Nasirabad District. Study Design: Observer-based research. Place and Duration of Study: From August 2022 to November 2022, the departments of general surgery and paediatrics will be located in (BMCH), Quetta, and Nasirabad DHQs Hospitals in Balochistan, Pakistan. Methodology: The 523 participants in total, 291 men and 232 women, had ELISA and ICT Screening tests for hepatitis B and C. Sequential selections of patients were made. Considering the medical history, clinical data, ultrasound results, and abnormal liver function tests of the patient, the diagnosis of chronic liver disease was made for each patient. Results: Compared to HBsAg, HCV had a prevalence rate of 14.3% versus 6.7%. In the age groups under 30 years old, Among the age groups between 31 and 40 years old, the prevalence of HBsAg was 7% (n = 10/138), 5% (n = 10/195), 13% (n = 15/116), 13% (n = 10/75), and 13% (n = 15/116), and in the age categories between 51 and 60 years old, it was 13% (n = 15/116). The prevalence was 13.7% in the under-30 age group (n = 20/146), 10% in the 31–40 age group (n = 20/195), 18.7% in the 51–60 age group (n = 20/106), 18.5% in the 51–60 age group (n = 15/81), and 18.7% in the 51–60 age group (n = 20/106). Conclusion: To increase public awareness of viral hepatitis transmission routes and prevention strategies, effective community-based health education campaigns must be undertaken right away. By working together with healthcare professionals and the appropriate team responsible for combating infectious diseases, risk factors including sharing razors and exposing oneself to dangerous medicine injections can be avoided.

References

Shanmugam S, Nichols AK, Saravanabalaji D, Welsch C, Yi M. HCV NS5A dimer interface residues regulate HCV replication by controlling its self-interaction, hyperphosphorylation, subcellular localization and interaction with cyclophilin A. PLoS pathogens. 2018;14(7):e1007177.

Younossi ZM. Non-alcoholic fatty liver disease–a global public health perspective. Journal of hepatology. 2019;70(3):531-44.

Katamba C, Philippe OO. Epidemiology of Hepatitis B Virus. IntechOpen. In Hepatitis B 2021.

Liu Y, Maya S, Ploss A. Animal models of hepatitis B virus infection–success, challenges, and future directions. Viruses. 2021;13(5):777.

Kamal SM, Ghoraba D. Epidemiology and modes of transmission of HCV in developing countries. InHepatitis C in developing countries. Academic Press. 2018;13-22.

Martinez MG, Villeret F, Testoni B, Zoulim F. Can we cure hepatitis B virus with novel direct‐acting antivirals?. Liver International. 2020;40:27-34.

Hebo HJ, Gemeda DH, Abdusemed KA. Hepatitis B and C viral infection: prevalence, knowledge, attitude, practice, and occupational exposure among healthcare workers of Jimma University Medical Center, southwest Ethiopia. The Scientific World Journal. 2019.

Djalilovna RD. The problem of prevalence of diffuse liver diseases. Art of Medicine. International Medical Scientific Journal. 2022;2(1).

Khetsuriani N, Lesi O, Desai S, Armstrong PA, Tohme RA. Progress toward the elimination of mother-to-child transmission of hepatitis B virus—worldwide, 2016–2021. Morbidity and Mortality Weekly Report. 2022;71(30):958.

Elbahrawy A, Ibrahim MK, Eliwa A, Alboraie M, Madian A, Aly HH. Current situation of viral hepatitis in Egypt. Microbiology and immunology. 2021;65(9):352-72.

Liu H, Zhang S, Shen Z, Ren G, Liu L, Ma Y, Zhang Y, Wang W. Development of a vaccine against Streptococcus agalactiae in fish based on truncated cell wall surface anchor proteins. Veterinary Record. 2016;179(14):359-.

Javed SO, Saleem A, Sahito AM, Hasan MM. Transfusion Transmitted Infections: A Present-Day Danger for Pakistan. The American Journal of Tropical Medicine and Hygiene. 2022;106(5):1311.

Saleem U, Aslam N, Siddique R, Iqbal S, Manan M. Hepatitis C virus: Its prevalence, risk factors and genotype distribution in Pakistan. European Journal of Inflammation. 2022;20:1721727X221144391.

Sagnelli C, Pisaturo M, Curatolo C, Codella AV, Coppola N, Sagnelli E. Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic. World Journal of Gastroenterology. 2021;27(42):7271.

Samo AA, Laghari ZA, Baig NM, Khoso GM. Prevalence and risk factors associated with hepatitis B and C in Nawabshah, Sindh, Pakistan. The American journal of tropical medicine and hygiene. 2021;104(3):1101.

Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SM, Jia J, Tian Q, Aggarwal R, Muljono DH, Omata M. Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission. The lancet Gastroenterology & hepatology. 2020;5(2):167-228.

Jafri SM, Gordon SC. Epidemiology of hepatitis C. Clinical liver disease. 2018;12(5):140.

Shaz SK, Ullah N, Rafique I. Prevalence of Hepatitis B and C in District Dir Upper, Khyber Pakhtunkhwa, Pakistan. Glob J Clin Virol. 2019;4(1):8-18.

Mubeen S, Javed MK, Bano M. Pattern of development of Hepatitis ‘C’and its relation to the family history among the patients in Liver Centre DHQ, Pakistan. International Journal of Advances in Health Sciences (IJHS). 2021;8(2):1-8.

Bari K, Luckett K, Kaiser T, Diwan T, Cuffy M, Schoech MR, Safdar K, Blackard JT, Apewokin S, Paterno F, Sherman KE. Hepatitis C transmission from seropositive, nonviremic donors to non–hepatitis C liver transplant recipients. Hepatology. 2018;67(5):1673-82.

Samo AA, Laghari ZA, Baig NM, Khoso GM. Prevalence and risk factors associated with hepatitis B and C in Nawabshah, Sindh, Pakistan. The American journal of tropical medicine and hygiene. 2021;104(3):1101.

Shahzad F, Abid F, Obaid AJ, Kumar Rai B, Ashraf M, Abdulbaqi AS. Forward stepwise logistic regression approach for determinants of hepatitis B & C among Hiv/Aids patients. International Journal of Nonlinear Analysis and Applications. 2021;12:1367-96.

Khan A, Afzal S, Yaqoob A, Fatima R, Ul Haq M, Junaid K, Nadir A. Epidemiology of viral hepatitis B and C in Punjab, Pakistan: a multicenter cross-sectional study, 2017-18. F1000Research. 2019;8:2065.

Saeed R, Hashmi I, Hashmi SM. Pakistan ranks third globally with the most unvaccinated children: is the impact of parental perception and attitude on immunization an essential contributing factor to an unsuccessful vaccination coverage?. Cureus. 2021;13(11).

Razavi-Shearer D, Gamkrelidze I, Nguyen MH, Chen DS, Van Damme P, Abbas Z, Abdulla M, Abou Rached A, Adda D, Aho I, Akarca U. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. The lancet Gastroenterology & hepatology. 2018;3(6):383-403.

Downloads

Published

2023-09-30